{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:04:44Z","timestamp":1782216284827,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T00:00:00Z","timestamp":1586649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T00:00:00Z","timestamp":1586649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100004051","name":"Kato Memorial Bioscience Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100004051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s12020-020-02298-1","type":"journal-article","created":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T07:02:28Z","timestamp":1586674948000},"page":"571-577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Acceleration of BRAFV600E-induced thyroid carcinogenesis by TGF\u03b2 signal deficiency in mice"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3830-2173","authenticated-orcid":false,"given":"Mika","family":"Shimamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5216-5785","authenticated-orcid":false,"given":"Tomomi","family":"Kurashige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rassul","family":"Kuatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9036-8735","authenticated-orcid":false,"given":"Masahiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5058-9349","authenticated-orcid":false,"given":"Yuji","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,12]]},"reference":[{"issue":"1","key":"2298_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/cco.0000000000000148","volume":"27","author":"R Vigneri","year":"2015","unstructured":"R. Vigneri, P. Malandrino, P. Vigneri, The changing epidemiology of thyroid cancer: why is incidence increasing? Curr Opin. Oncol. 27(1), 1\u20137 (2015). https:\/\/doi.org\/10.1097\/cco.0000000000000148","journal-title":"Curr Opin. Oncol."},{"issue":"3","key":"2298_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"The Cancer Genome Atlas Research Network.","year":"2014","unstructured":"The Cancer Genome Atlas Research Network., Integrated genomic characterization of papillary thyroid carcinoma. Cell 159(3), 676\u2013690 (2014). https:\/\/doi.org\/10.1016\/j.cell.2014.09.050","journal-title":"Cell"},{"issue":"8","key":"2298_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1089\/thy.2007.0303","volume":"19","author":"MA Pisarev","year":"2009","unstructured":"M.A. Pisarev, L. Thomasz, G.J. Juvenal, Role of transforming growth factor beta in the regulation of thyroid function and growth. Thyroid 19(8), 881\u2013892 (2009). https:\/\/doi.org\/10.1089\/thy.2007.0303","journal-title":"Thyroid"},{"issue":"1-2","key":"2298_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0303-7207(93)90024-E","volume":"95","author":"M Taton","year":"1993","unstructured":"M. Taton, F. Lamy, P.P. Roger, J.E. Dumont, General inhibition by transforming growth factor beta 1 of thyrotropin and cAMP responses in human thyroid cells in primary culture. Mol. Cell. Endocrinol. 95(1-2), 13\u201321 (1993)","journal-title":"Mol. Cell. Endocrinol."},{"issue":"11","key":"2298_CR5","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/sj.onc.1201662","volume":"16","author":"C Carneiro","year":"1998","unstructured":"C. Carneiro, C.V. Alvarez, J. Zalvide, A. Vidal, F. Dominguez, TGF-beta1 actions on FRTL-5 cells provide a model for the physiological regulation of thyroid growth. Oncogene 16(11), 1455\u20131465 (1998). https:\/\/doi.org\/10.1038\/sj.onc.1201662","journal-title":"Oncogene"},{"issue":"3","key":"2298_CR6","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1091\/mbc.11.3.1061","volume":"11","author":"F Depoortere","year":"2000","unstructured":"F. Depoortere, I. Pirson, J. Bartek, J.E. Dumont, P.P. Roger, Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1). Mol. Biol. Cell 11(3), 1061\u20131076 (2000). https:\/\/doi.org\/10.1091\/mbc.11.3.1061","journal-title":"Mol. Biol. Cell"},{"issue":"9","key":"2298_CR7","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.1210\/endo.140.9.6961","volume":"140","author":"A Franzen","year":"1999","unstructured":"A. Franzen, E. Piek, B. Westermark, P. ten Dijke, N.E. Heldin, Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function. Endocrinology 140(9), 4300\u20134310 (1999). https:\/\/doi.org\/10.1210\/endo.140.9.6961","journal-title":"Endocrinology"},{"issue":"3","key":"2298_CR8","first-page":"1418","volume":"9","author":"W Sun","year":"2017","unstructured":"W. Sun, Y. Xu, C. Zhao, F. Hao, D. Chen, J. Guan, K. Zhang, Targeting TGF-beta1 suppresses survival of and invasion by anaplastic thyroid carcinoma cells. Am. J. Transl. Res. 9(3), 1418\u20131425 (2017)","journal-title":"Am. J. Transl. Res."},{"issue":"12","key":"2298_CR9","first-page":"2581","volume":"20","author":"Y Li","year":"2016","unstructured":"Y. Li, D. Chen, F.Y. Hao, K.J. Zhang, Targeting TGF-beta1 and AKT signal on growth and metastasis of anaplastic thyroid cancer cell in vivo. Eur. Rev. Med Pharmacol. Sci. 20(12), 2581\u20132587 (2016)","journal-title":"Eur. Rev. Med Pharmacol. Sci."},{"key":"2298_CR10","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.12659\/MSM.898702","volume":"22","author":"Q Yin","year":"2016","unstructured":"Q. Yin, S. Liu, A. Dong, X. Mi, F. Hao, K. Zhang, Targeting transforming growth factor-beta1 (TGF-beta1) inhibits tumorigenesis of anaplastic thyroid carcinoma cells through ERK1\/2-NFkappakB-PUMA signaling. Med Sci. Monit. 22, 2267\u20132277 (2016)","journal-title":"Med Sci. Monit."},{"issue":"5","key":"2298_CR11","first-page":"2196","volume":"8","author":"K Zhang","year":"2016","unstructured":"K. Zhang, X. Liu, F. Hao, A. Dong, D. Chen, Targeting TGF-beta1 inhibits invasion of anaplastic thyroid carcinoma cell through SMAD2-dependent S100A4-MMP-2\/9 signalling. Am. J. Transl. Res. 8(5), 2196\u20132209 (2016)","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"2298_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1507\/endocrj.EJ13-0475","volume":"61","author":"M Shimamura","year":"2014","unstructured":"M. Shimamura, M. Nakahara, T. Kurashige, K. Yasui, M. Nakashima, Y. Nagayama, Disruption of transforming growth factor-beta signaling in thyroid follicular epithelial cells or intrathyroidal fibroblasts does not promote thyroid carcinogenesis. Endocr. J. 61(3), 297\u2013302 (2014)","journal-title":"Endocr. J."},{"issue":"8","key":"2298_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201365","volume":"13","author":"M Shimamura","year":"2018","unstructured":"M. Shimamura, N. Shibusawa, T. Kurashige, Z. Mussazhanova, H. Matsuzaki, M. Nakashima, M. Yamada, Y. Nagayama, Mouse models of sporadic thyroid cancer derived from BRAFV600E alone or in combination with PTEN haploinsufficiency under physiologic TSH levels. PLoS ONE 13(8), e0201365 (2018). https:\/\/doi.org\/10.1371\/journal.pone.0201365","journal-title":"PLoS ONE"},{"issue":"5659","key":"2298_CR14","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.1090922","volume":"303","author":"NA Bhowmick","year":"2004","unstructured":"N.A. Bhowmick, A. Chytil, D. Plieth, A.E. Gorska, N. Dumont, S. Shappell, M.K. Washington, E.G. Neilson, H.L. Moses, TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303(5659), 848\u2013851 (2004). https:\/\/doi.org\/10.1126\/science.1090922. [doi] 03\/5659\/848","journal-title":"Science"},{"issue":"4","key":"2298_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1101\/gad.1516407","volume":"21","author":"D Dankort","year":"2007","unstructured":"D. Dankort, E. Filenova, M. Collado, M. Serrano, K. Jones, M. McMahon, A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Gene Dev. 21(4), 379\u2013384 (2007). https:\/\/doi.org\/10.1101\/gad.1516407","journal-title":"Gene Dev."},{"issue":"11","key":"2298_CR16","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1210\/en.2013-1174","volume":"154","author":"M Shimamura","year":"2013","unstructured":"M. Shimamura, M. Nakahara, F. Orim, T. Kurashige, N. Mitsutake, M. Nakashima, S. Kondo, M. Yamada, R. Taguchi, S. Kimura, Y. Nagayama, Postnatal expression of BRAFV600E does not induce thyroid cancer in mouse models of thyroid papillary carcinoma. Endocrinology 154(11), 4423\u20134430 (2013). https:\/\/doi.org\/10.1210\/en.2013-1174","journal-title":"Endocrinology"},{"issue":"6","key":"2298_CR17","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1073\/pnas.94.6.2386","volume":"94","author":"XJ Wang","year":"1997","unstructured":"X.J. Wang, D.A. Greenhalgh, J.R. Bickenbach, A. Jiang, D.S. Bundman, T. Krieg, R. Derynck, D.R. Roop, Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition. Proc. Natl. Acad. Sci. USA 94(6), 2386\u20132391 (1997)","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"2298_CR18","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1093\/emboj\/16.10.2621","volume":"16","author":"EP Bottinger","year":"1997","unstructured":"E.P. Bottinger, J.L. Jakubczak, I.S. Roberts, M. Mumy, P. Hemmati, K. Bagnall, G. Merlino, L.M. Wakefield, Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas. EMBO J. 16(10), 2621\u20132633 (1997). https:\/\/doi.org\/10.1093\/emboj\/16.10.2621","journal-title":"EMBO J."},{"issue":"22","key":"2298_CR19","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1101\/gad.1475506","volume":"20","author":"H Ijichi","year":"2006","unstructured":"H. Ijichi, A. Chytil, A.E. Gorska, M.E. Aakre, Y. Fujitani, S. Fujitani, C.V. Wright, H.L. Moses, Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression. Gene Dev. 20(22), 3147\u20133160 (2006). https:\/\/doi.org\/10.1101\/gad.1475506","journal-title":"Gene Dev."},{"issue":"20","key":"2298_CR20","doi-asserted-by":"publisher","first-page":"9837","DOI":"10.1158\/0008-5472.Can-06-0890","volume":"66","author":"NM Munoz","year":"2006","unstructured":"N.M. Munoz, M. Upton, A. Rojas, M.K. Washington, L. Lin, A. Chytil, E.G. Sozmen, B.B. Madison, A. Pozzi, R.T. Moon, H.L. Moses, W.M. Grady, Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation. Cancer Res. 66(20), 9837\u20139844 (2006). https:\/\/doi.org\/10.1158\/0008-5472.Can-06-0890","journal-title":"Cancer Res."},{"issue":"1","key":"2298_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/path.4930","volume":"243","author":"Y Gao","year":"2017","unstructured":"Y. Gao, P. Lin, J.P. Lydon, Q. Li, Conditional abrogation of transforming growth factor-beta receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice. J. Pathol. 243(1), 89\u201399 (2017). https:\/\/doi.org\/10.1002\/path.4930","journal-title":"J. Pathol."},{"issue":"6","key":"2298_CR22","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1158\/0008-5472.Can-04-3272","volume":"65","author":"E Forrester","year":"2005","unstructured":"E. Forrester, A. Chytil, B. Bierie, M. Aakre, A.E. Gorska, A.R. Sharif-Afshar, W.J. Muller, H.L. Moses, Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res. 65(6), 2296\u20132302 (2005). https:\/\/doi.org\/10.1158\/0008-5472.Can-04-3272","journal-title":"Cancer Res."},{"issue":"5","key":"2298_CR23","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1053\/j.gastro.2009.01.066","volume":"136","author":"P Trobridge","year":"2009","unstructured":"P. Trobridge, S. Knoblaugh, M.K. Washington, N.M. Munoz, K.D. Tsuchiya, A. Rojas, X. Song, C.M. Ulrich, T. Sasazuki, S. Shirasawa, W.M. Grady, TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway. Gastroenterology 136(5), 1680\u20131688.e1687 (2009). https:\/\/doi.org\/10.1053\/j.gastro.2009.01.066","journal-title":"Gastroenterology"},{"issue":"1","key":"2298_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/CCO.0b013e32835b6371","volume":"25","author":"Y Katsuno","year":"2013","unstructured":"Y. Katsuno, S. Lamouille, R. Derynck, TGF-beta signaling and epithelial-mesenchymal transition in cancer progression. Curr. Opin. Oncol. 25(1), 76\u201384 (2013). https:\/\/doi.org\/10.1097\/CCO.0b013e32835b6371","journal-title":"Curr. Opin. Oncol."},{"issue":"8","key":"2298_CR25","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1073\/pnas.0610733104","volume":"104","author":"V Vasko","year":"2007","unstructured":"V. Vasko, A.V. Espinosa, W. Scouten, H. He, H. Auer, S. Liyanarachchi, A. Larin, V. Savchenko, G.L. Francis, A. de la Chapelle, M. Saji, M.D. Ringel, Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc. Natl. Acad. Sci. USA 104(8), 2803\u20132808 (2007). https:\/\/doi.org\/10.1073\/pnas.0610733104","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"21","key":"2298_CR26","doi-asserted-by":"publisher","first-page":"8317","DOI":"10.1158\/0008-5472.Can-09-1248","volume":"69","author":"G Riesco-Eizaguirre","year":"2009","unstructured":"G. Riesco-Eizaguirre, I. Rodriguez, A. De la Vieja, E. Costamagna, N. Carrasco, M. Nistal, P. Santisteban, The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Cancer Res. 69(21), 8317\u20138325 (2009). https:\/\/doi.org\/10.1158\/0008-5472.Can-09-1248","journal-title":"Cancer Res."},{"issue":"3","key":"2298_CR27","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.2353\/ajpath.2007.061211","volume":"171","author":"RG Hardy","year":"2007","unstructured":"R.G. Hardy, C. Vicente-Duenas, I. Gonzalez-Herrero, C. Anderson, T. Flores, S. Hughes, C. Tselepis, J.A. Ross, I. Sanchez-Garcia, Snail family transcription factors are implicated in thyroid carcinogenesis. Am. J. Pathol. 171(3), 1037\u20131046 (2007). https:\/\/doi.org\/10.2353\/ajpath.2007.061211","journal-title":"Am. J. Pathol."},{"issue":"28","key":"2298_CR28","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1038\/onc.2011.44","volume":"30","author":"JA Knauf","year":"2011","unstructured":"J.A. Knauf, M.A. Sartor, M. Medvedovic, E. Lundsmith, M. Ryder, M. Salzano, Y.E. Nikiforov, T.J. Giordano, R.A. Ghossein, J.A. Fagin, Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFbeta signaling. Oncogene 30(28), 3153\u20133162 (2011). https:\/\/doi.org\/10.1038\/onc.2011.44","journal-title":"Oncogene"},{"issue":"5","key":"2298_CR29","doi-asserted-by":"publisher","first-page":"R203","DOI":"10.1530\/eje-16-0202","volume":"175","author":"G Riesco-Eizaguirre","year":"2016","unstructured":"G. Riesco-Eizaguirre, P. Santisteban, ENDOCRINE TUMOURS: Advances in the molecular pathogenesis of thyroid cancer: lessons from the cancer genome. Eur. J. Endocrinol. 175(5), R203\u2013R217 (2016). https:\/\/doi.org\/10.1530\/eje-16-0202","journal-title":"Eur. J. Endocrinol."},{"issue":"7","key":"2298_CR30","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1210\/jc.2006-2707","volume":"92","author":"C Durante","year":"2007","unstructured":"C. Durante, E. Puxeddu, E. Ferretti, R. Morisi, S. Moretti, R. Bruno, F. Barbi, N. Avenia, A. Scipioni, A. Verrienti, E. Tosi, A. Cavaliere, A. Gulino, S. Filetti, D. Russo, BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism. J. Clin. Endocrinol. Metab. 92(7), 2840\u20132843 (2007). https:\/\/doi.org\/10.1210\/jc.2006-2707","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"2298_CR31","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1089\/thy.2018.0695","volume":"29","author":"A Tanaka","year":"2019","unstructured":"A. Tanaka, M. Matsuse, V. Saenko, T. Nakao, K. Yamanouchi, C. Sakimura, H. Yano, E. Nishihara, M. Hirokawa, K. Suzuki, A. Miyauchi, S. Eguchi, K.I. Yoshiura, S. Yamashita, T. Nagayasu, N. Mitsutake, TERT mRNA expression as a novel prognostic marker in papillary thyroid carcinomas. Thyroid 29(8), 1105\u20131114 (2019). https:\/\/doi.org\/10.1089\/thy.2018.0695","journal-title":"Thyroid"},{"issue":"6","key":"2298_CR32","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41388-018-0480-0","volume":"38","author":"M Nakano","year":"2019","unstructured":"M. Nakano, Y. Kikushige, K. Miyawaki, Y. Kunisaki, S. Mizuno, K. Takenaka, S. Tamura, Y. Okumura, M. Ito, H. Ariyama, H. Kusaba, M. Nakamura, T. Maeda, E. Baba, K. Akashi, Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer. Oncogene 38(6), 780\u2013793 (2019). https:\/\/doi.org\/10.1038\/s41388-018-0480-0","journal-title":"Oncogene"},{"issue":"10","key":"2298_CR33","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/cdd.2017.92","volume":"24","author":"P Cammareri","year":"2017","unstructured":"P. Cammareri, D.F. Vincent, M.C. Hodder, R.A. Ridgway, C. Murgia, M. Nobis, A.D. Campbell, J. Varga, D.J. Huels, C. Subramani, K.L.H. Prescott, C. Nixon, A. Hedley, S.T. Barry, F.R. Greten, G.J. Inman, O.J. Sansom, TGFbeta pathway limits dedifferentiation following WNT and MAPK pathway activation to suppress intestinal tumourigenesis. Cell Death Differ. 24(10), 1681\u20131693 (2017). https:\/\/doi.org\/10.1038\/cdd.2017.92","journal-title":"Cell Death Differ."},{"issue":"34","key":"2298_CR34","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.1038\/sj.onc.1208603","volume":"24","author":"D Lazzereschi","year":"2005","unstructured":"D. Lazzereschi, F. Nardi, A. Turco, L. Ottini, C. D\u2019Amico, R. Mariani-Costantini, A. Gulino, A. Coppa, A complex pattern of mutations and abnormal splicing of Smad4 is present in thyroid tumours. Oncogene 24(34), 5344\u20135354 (2005). https:\/\/doi.org\/10.1038\/sj.onc.1208603","journal-title":"Oncogene"},{"issue":"5","key":"2298_CR35","doi-asserted-by":"publisher","first-page":"536","DOI":"10.20945\/2359-3997000000172","volume":"63","author":"CS Fuziwara","year":"2019","unstructured":"C.S. Fuziwara, K.C. Saito, E.T. Kimura, Interplay of TGFbeta signaling and microRNA in thyroid cell loss of differentiation and cancer progression. Arch. Endocrinol. Metab. 63(5), 536\u2013544 (2019). https:\/\/doi.org\/10.20945\/2359-3997000000172","journal-title":"Arch. Endocrinol. Metab."},{"issue":"4","key":"2298_CR36","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1590\/s0004-27302010000400010","volume":"54","author":"SE Matsuo","year":"2010","unstructured":"S.E. Matsuo, A.P. Fiore, S.M. Siguematu, K.N. Ebina, C.U. Friguglietti, M.C. Ferro, M.A. Kulcsar, E.T. Kimura, Expression of SMAD proteins, TGF-beta\/activin signaling mediators, in human thyroid tissues. Arq. Bras. Endocrinol. Metab. 54(4), 406\u2013412 (2010). https:\/\/doi.org\/10.1590\/s0004-27302010000400010","journal-title":"Arq. Bras. Endocrinol. Metab."},{"issue":"49","key":"2298_CR37","doi-asserted-by":"publisher","first-page":"7819","DOI":"10.1038\/sj.onc.1207029","volume":"22","author":"SB Bravo","year":"2003","unstructured":"S.B. Bravo, S. Pampin, J. Cameselle-Teijeiro, C. Carneiro, F. Dominguez, F. Barreiro, C.V. Alvarez, TGF-beta-induced apoptosis in human thyrocytes is mediated by p27kip1 reduction and is overridden in neoplastic thyrocytes by NF-kappaB activation. Oncogene 22(49), 7819\u20137830 (2003). https:\/\/doi.org\/10.1038\/sj.onc.1207029","journal-title":"Oncogene"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02298-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-020-02298-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02298-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T23:26:43Z","timestamp":1618183603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-020-02298-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,12]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["2298"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02298-1","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,12]]},"assertion":[{"value":"13 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}